| Nov 19, 2014
| 1:25 PM
NEW YORK (Reuters) - After months of fending off a hostile bid, Allergan Inc Chief Executive David Pyott made the right call in selling to rival Actavis Plc , whose stock price could nearly double in the next two years, a prominent investor said on...
| Nov 17, 2014
| 8:30 PM
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.
The deal thwarts a...
| Oct 27, 2014
| 5:10 PM
As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm.
J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
| Oct 9, 2014
| 8:22 AM
Botox maker Allergan lifted its profit outlook Thursday as it tries to stave off a takeover attempt from a Canadian rival.
The Irvine-based drug maker said it expects to earn between $1.76 and $1.78 a share during the third quarter, up from its previous...
| Jul 22, 2014
| 5:03 PM
Feelings were mixed among Allergan Inc. employees one day after the Botox maker announced 1,500 job cuts, mostly in Southern California.
Outside of Allergan’s Irvine campus, where the bulk of the 650 research and development jobs the company...
| Jul 21, 2014
| 12:59 PM
Most of the 1,500 job cuts that Botox maker Allergan Inc. announced Monday morning will be made in Southern California, the company’s chief executive said.
Allergan plans to eliminate 650 research and development jobs, the bulk of them at its...
| Jul 22, 2014
Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival.
Stung by criticism that it'...
| Jun 23, 2014
| 11:53 AM
Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm.
Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
| Jun 19, 2014
| 4:54 PM
Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
| Jun 10, 2014
| 12:02 PM
The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution.
Valeant Pharmaceuticals International Inc. last month...
| Apr 21, 2014
| 8:41 PM
Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox.
Ackman and Valeant Pharmaceuticals International Inc. have already...